These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 7973002)

  • 1. [Postmarketing surveillance of secondary effects of vaccines].
    Duclos P
    Rev Epidemiol Sante Publique; 1994; 42(5):425-33. PubMed ID: 7973002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Surveillance of secondary effects of vaccination].
    Duclos P
    Sante; 1994; 4(3):215-20. PubMed ID: 7921691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccine adverse events reported in post-marketing study of the Kitasato Institute from 1994 to 2004.
    Nakayama T; Onoda K
    Vaccine; 2007 Jan; 25(3):570-6. PubMed ID: 16945455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The monitoring of adverse events following immunization.
    Tatley M
    N Z Med J; 2002 Nov; 115(1165):U247; author reply U247. PubMed ID: 12552289
    [No Abstract]   [Full Text] [Related]  

  • 5. Suggestions for improving the monitoring of adverse events following immunization in New Zealand.
    Miller M; Turner N
    N Z Med J; 2002 Sep; 115(1162):U186. PubMed ID: 12386665
    [No Abstract]   [Full Text] [Related]  

  • 6. Safety monitoring in vaccine development and immunization.
    Lee CJ; Lee LH; Lu CH; Huang YJ; Chu ML
    Acta Paediatr Taiwan; 2006; 47(1):7-13. PubMed ID: 17016963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of vaccine safety after the events of 11 September 2001: role of cohort and case-control studies.
    Chen RT
    Vaccine; 2004 May; 22(15-16):2047-53. PubMed ID: 15121321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccine safety: current systems and recent findings.
    Wharton M
    Curr Opin Pediatr; 2010 Feb; 22(1):88-93. PubMed ID: 19952750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Field evaluation of vaccine safety.
    Tozzi AE
    Vaccine; 2004 May; 22(15-16):2091-5. PubMed ID: 15121330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse events after anthrax vaccination reported to the Vaccine Adverse Event Reporting System (VAERS), 1990-2007.
    Niu MT; Ball R; Woo EJ; Burwen DR; Knippen M; Braun MM;
    Vaccine; 2009 Jan; 27(2):290-7. PubMed ID: 18992783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse events following immunization: 1990.
    Sokhey J
    Indian Pediatr; 1991 Jun; 28(6):593-607. PubMed ID: 1748507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Adverse reaction surveillance system for vaccination in the Republic of Cuba].
    Galindo Santana BM; Galindo Sardiña MA; Pérez Rodríguez A
    Rev Cubana Med Trop; 1999; 51(3):194-200. PubMed ID: 10887588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccinovigilance in Europe--need for timeliness, standardization and resources.
    Lankinen KS; Pastila S; Kilpi T; Nohynek H; Mäkelä PH; Olin P
    Bull World Health Organ; 2004 Nov; 82(11):828-35. PubMed ID: 15640918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of postlicensure safety of rotavirus vaccines, with emphasis on intussusception.
    Bines JE; Patel M; Parashar U
    J Infect Dis; 2009 Nov; 200 Suppl 1():S282-90. PubMed ID: 19817611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methods of ensuring vaccine safety.
    Ball R
    Expert Rev Vaccines; 2002 Aug; 1(2):161-8. PubMed ID: 12901555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring and assessing vaccine safety: a European perspective.
    Lopalco PL; Johansen K; Ciancio B; De Carvalho Gomes H; Kramarz P; Giesecke J
    Expert Rev Vaccines; 2010 Apr; 9(4):371-80. PubMed ID: 20370548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiological approaches to safety investigations.
    Wood JL; Adams VJ
    Vet Microbiol; 2006 Oct; 117(1):66-70. PubMed ID: 16713135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current thoughts on the risks and benefits of immunisation.
    Duclos P; Bentsi-Enchill A
    Drug Saf; 1993 Jun; 8(6):404-13. PubMed ID: 8329146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postmarketing safety surveillance for typhoid fever vaccines from the Vaccine Adverse Event Reporting System, July 1990 through June 2002.
    Begier EM; Burwen DR; Haber P; Ball R;
    Clin Infect Dis; 2004 Mar; 38(6):771-9. PubMed ID: 14999618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developing a national system for dealing with adverse events following immunization.
    Mehta U; Milstien JB; Duclos P; Folb PI
    Bull World Health Organ; 2000; 78(2):170-7. PubMed ID: 10743281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.